Pneumologia

Estudo randomizado | Aspiração simples vs. drenagem para pneumotórax completo

31 Jan, 2023 | 12:08h

Simple Aspiration Versus Drainage for Complete Pneumothorax: A Randomized Non-Inferiority Trial – Am J Respir Crit Care Med (link para o resumo – $ para o texto completo)

 

---

Resumo executivo | Diretrizes para diagnóstico e tratamento da síndrome da angústia respiratória aguda pediátrica

23 Jan, 2023 | 13:44h

Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2) – Pediatric Critical Care Medicine

 

---

Breve revisão e algoritmo | Tratamento da tuberculose latente

23 Jan, 2023 | 13:31h

Management of Latent Tuberculosis Infection – JAMA (gratuito por tempo limitado)

 

---

OMS atualiza diretrizes de COVID-19 sobre máscaras, tratamentos e cuidados do paciente

16 Jan, 2023 | 11:17h

WHO updates COVID-19 guidelines on masks, treatments and patient care – World Health Organization

Diretrizes OMS atualizadas:

Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023 – World Health Organization

Clinical management of COVID-19: Living guideline, 13 January 2023 – World Health Organization – World Health Organization

Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization

 

---

Estudo randomizado | Fluvoxamina não é melhor que placebo em pacientes ambulatoriais com COVID-19 leve a moderada

16 Jan, 2023 | 11:12h

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Lack of Benefit of Fluvoxamine for COVID-19 – JAMA

Entrevista com a autora: Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19 – JAMA

Comentário: Trial finds that fluvoxamine doesn’t speed COVID recovery – CIDRAP

 

Comentário no Twitter

Among outpatients with mild to moderate #COVID19, treatment with 50 mg of fluvoxamine twice daily for 10 days, compared with placebo, did not improve time to sustained recovery. https://t.co/4QgBssqFSU pic.twitter.com/RMZ6mqlx6u

— JAMA (@JAMA_current) January 12, 2023

 

---

Revisão | Tratamento do trauma torácico

16 Jan, 2023 | 10:32h

Management of thoracic trauma – Anaesthesia

 

---

Estudo randomizado | Uso de zinco por via oral 2 vezes/dia no tratamento de pacientes com COVID-19.

13 Dez, 2022 | 15:16h

Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial – Clinical Infectious Diseases

 

---

Revisão | Doenças pulmonares parasitárias.

13 Dez, 2022 | 15:03h

Parasitic lung diseases – European Respiratory Review

 

---

Estudo de coorte | Uso de tabaco e incidência de desfechos adversos de saúde oral.

13 Dez, 2022 | 15:01h

Tobacco Use and Incidence of Adverse Oral Health Outcomes Among US Adults in the Population Assessment of Tobacco and Health Study – JAMA Network Open

Comentário: Expert reaction to study looking at smoking, vaping and oral health – Science Media Centre

 

---

Revisão | Função da oxigenação por membrana extracorpórea e embolectomia cirúrgica na embolia pulmonar aguda.

13 Dez, 2022 | 14:55h

Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism – Current Opinion in Pulmonary Medicine

 

---